Hematological Malignancies and Fertility.

Area of Science:

• Oncology and Reproductive Medicine
• Hematological Malignancies
• Fertility Preservation

Background:

• Improved survival rates for hematological malignancies necessitate focus on long-term quality of life.
• Sparing reproductive potential is a key goal for both male and female cancer patients.
• Early consultation with reproductive specialists is crucial for maximizing parenting potential in survivors.

Purpose of the Study:

• To review the safety and efficacy of fertility preservation methods in patients with hematological malignancies.
• To analyze pregnancy outcomes following fertility preservation in survivors of hematological cancers.
• To provide an overview of available reproductive options before gonadotoxic therapy.

Main Methods:

• Comprehensive literature review on fertility preservation techniques.
• Analysis of safety and efficacy data for cryopreservation of oocytes, embryos, ovarian tissue, sperm, and testicular tissue.
• Evaluation of pregnancy outcomes in patients with hematological malignancies who underwent fertility preservation.

Main Results:

• Cryopreservation of gametes and tissues are feasible options for adult patients prior to cancer treatment.
• Fertility preservation methods should be considered experimental in the pre-pubertal population.
• The review synthesizes data on the success rates and safety profiles of various preservation techniques.

Conclusions:

• Fertility preservation is an essential consideration for patients with hematological malignancies undergoing potentially gonadotoxic treatments.
• Informed consultation and timely intervention significantly increase the likelihood of future parenthood for survivors.
• Continued research is vital to further refine techniques and outcomes for fertility preservation in cancer patients.